INTRODUCTION
Default options are the action that takes place if no alternative choice is selected. Default options are abundant within electronic health records (EHRs) and can be used to significantly influence behavior. 1 For example, we found that changing generic medication prescription settings in the EHR from opt-in to opt-out increased generic prescription rates across our health system from 75 to 98% in the first 7 months after implementation. 2 However, the longer-term impact of default options has not been well examined and evidence on the sustainability of other types of nudges for reducing inappropriate antibiotic prescribing has been mixed. 3, 4 The objective of this study was to evaluate the 2.5-year durability of the increase in generic prescribing rates after changing EHR prescription default settings.
METHODS
Similar to prior work, 2 we compared monthly generic prescription rates from January 2014 to May 2017 for all outpatient clinics at Penn Medicine for oral medications often prescribed for nine common medical conditions including acid reflux, anxiety and/or insomnia, bacterial infection, depression, diabetes, hyperlipidemia, hypertension and/or congestive heart failure, hypothyroidism, and pain. Medications were excluded if they did not have a generic equivalent available during the entire study period, were combination pills, were refills of an existing medication, or were prescribed at our health system on average less than 100 times per month. Data was obtained from Clarity, an Epic reporting database. Generic prescribing rates were compared between the pre-intervention period (January 2014 to October 2014) and the postintervention period (December 2014 to May 2017) using χ 2 tests. We used a significance level of P < .05 and hypothesis tests were two-sided. This study was approved by the University of Pennsylvania's institutional review board.
RESULTS
The sample comprised 76 medications. During the 10-month pre-intervention period, 75.4% (542,961/720,318) of prescriptions were generic. During the 30-month post-intervention period, 98.4% (2,558,039/2,599,045) of prescriptions were generic (P < .001 compared to pre-intervention period). Figure 1 displays monthly prescriptions rates which were mostly flat during the post-intervention period. Levothyroxine was an outlier with monthly generic prescription rates in the postintervention period ranging from 76.1 to 80.8%.
DISCUSSION
Our study has two main findings. First, overall increases in generic prescription rates across the health system were sustained 2.5 years after implementation of an opt-out generic prescribing system within the EHR. In the USA, generic medications are still often under prescribed leading to unnecessary cost and lower adherence. 5 Health systems may be able to use default options to change clinician prescribing behaviors over longer-term periods. Second, clinicians opted-out of generic levothyroxine for the brand name prescription 20-25% of the time. This confirms findings from our prior work 2 in which clinicians recognize that generic and brand versions of this medication may differ in formulation, and that patients coming to our health system already on the brand formulation should remain on it. This demonstrates that clinician autonomy in medical decision-making is maintained and that opt out rates were constant over this longer-term period.
Our study is limited to one health system and data on prescription orders. Some brand name prescriptions could have been substituted to generic at the pharmacy. However, evidence indicates that substantial excess spending on brand name prescriptions are still occurs. 5 Our study is also limited to only new prescriptions and default settings for refilled prescriptions were not changed.
To our knowledge, this is one of the longest follow-up evaluations of the impact of nudges on clinician behavior.
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Our findings indicate that changing default options in the electronic health record can lead to sustained changes in clinician behavior.
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